Tuesday, 26 October

07:30 – 08:15

Breakfast / Satellite Symposium

08:15 – 09:30

Session 1: Aortic Valve Disease

Chair: Felix C. Tanner, Zurich

Advanced imaging in aortic stenosis

Jeroen J. Bax, Leiden

TAVI in low and moderate risk patients

Stephan Windecker, Berne

Unresolved issues in TAVI

Stefan Toggweiler, Lucerne

The 2021 ESC Guidelines on valvular heart disease

Alec Vahanian, Paris
09:30 – 10:00

Coffee

10:00 – 11:30

Parallel Sessions


1. Mitral and Tricuspid Valve Disease

Chair: Giovanni Pedrazzini, Lugano / Michael Gatzoulis. London

  • Imaging the mitral valve
    Michel Zuber, Othmarsingen
  • Management of MR: surgical or percutaneous?
    Francesco Maisano, Milan
  • Tricuspid regurgitation: a new therapeutic target
    Georg Nickenig, Bonn

2. Covid-19 and the Heart

Chair: Richard Grocott-Mason, London / Bernard Gersh, Rochester

  • The acute impact of Covid-19 on the cardiovascular system
    Susanna Price, London
  • Collateral damage of Covid-19
    Thomas F. Lüscher, London
  • The Long Covid syndrome
    Betty Raman, Oxford
  • Venous thromboembolism and Covid-19
    tbd
12:00 – 13:15

Lunch / Satellite Symposium

13:30 – 15:00

Session 3: Heart Failure I: Established and Novel Drugs

Chair: John Cleland, Glasgow

From ACE-inhibition to mineralocorticoid receptor antagonism

M. A. Pfeffer, Boston

Angiotensin receptor antagonism and neprilysin inhibition across the spectrum of ejection fractions in heart failure

K. B. Swedberg, Gothenburg

SGLT2 inhibitors in heart failure: when and how to use?

Milton Packer, Dallas

Cyclic GMP activators: The VICORIA trial

Burkart Pieske, Berlin

Cardiac-specific myosin activators: GALACTIC-HF

John Cleland, Glasgow
15:00 – 15:15

Coffee

15:15 – 16:00

Parallel Sessions


1. Meet the Expert Session: How to implement the 2021 ESC Guidelines in Heart Failure Algorithm for sequencing drug treatment in HFrEF

Moderators: Marco Metra, Brescia / Christian Mueller, Basel / Roger Hullin, Lausanne

2. Meet the Expert Session: Imaging the Mitral Valve

Moderators: Victoria Delgado, Leiden / Michel Zuber, Othmarsingen / Simon Stämpfli, Lucerne

16:00 – 17:00

Session 4: Heart Failure II: Open Issues in Heart Failure

Chair: Milton Packer, Dallas / M. A. Pfeffer, Boston

The 2021 ESC Guidelines on heart failure

Marco Metra, Brescia

Clinical use of biomarkers in heart failure

Christian Müller, Basel

Remote monitoring in heart failure

Gerd Hindricks, Leipzig
17:00 – 17:15

Wrap Up / Closing Remarks